Westfield Capital Management CO LP Rhythm Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $19.3 Billion
- Q1 2025
A detailed history of Westfield Capital Management CO LP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,341,092 shares of RYTM stock, worth $133 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
1,341,092Holding current value
$133 Million% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
249Shares Held
63.4MCall Options Held
403KPut Options Held
39.8K-
Black Rock Inc. New York, NY6.74MShares$666 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$601 Million6.69% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$554 Million3.54% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$482 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$355 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.51B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...